查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040927

醫療植入市場預測至2034年—按產品、材料、最終用戶和地區分類的全球分析

Medical Implant Market Forecasts to 2034 - Global Analysis By Product, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫療植入市場規模將達到 1,283 億美元，並在預測期內以 9.2% 的複合年成長率成長，到 2034 年將達到 2,600 億美元。

醫療植入市場涵蓋了旨在透過手術植入人體內的各類設備，其用途包括替代或支撐受損的生物結構、改善身體機能或監測健康狀況。植入式醫療設備用途廣泛，包括恢復器官功能、控制慢性疾病和改善運動功能。此外，人工電子耳有助於恢復聽力，胰島素幫浦有助於控制糖尿病。這些設備不僅有助於延長壽命、提升生活品質，還能幫助患者恢復身體機能。

根據美國癌症協會2023年的報告，2022年美國新增乳癌病例為287,850例，預計2023年女性侵襲性乳癌將達297,790例。美國美容整形外科學會的統計數據顯示，2021年共進行了147,684例乳房植入取出和更換手術，佔手術收入的6%。

醫療費用不斷上漲

隨著各國投入大量資源改善醫療基礎設施和服務，包括植入式醫療器材在內的先進醫療技術的普及和應用也隨之增加。隨著對高品質醫療服務的日益重視，不斷上漲的醫療成本表明各國致力於推進醫療干預措施，而植入式醫療器材尤其成為為各種疾病提供精密、有效且往往能改善患者生活品質的解決方案的關鍵要素。

高成本

複雜的研發流程、生產製造流程以及嚴格的監管核准要求推高了生產成本。因此，這些成本往往會轉嫁給醫療服務提供者，最終轉嫁給患者，使植入式醫療解決方案成為經濟負擔。這種高昂的經濟門檻會限制患者獲得醫療植入的機會，並阻礙他們尋求這些先進的治療方案，尤其是在醫療預算有限的地區。然而，成本也是加劇現有醫療資源不平等的因素，因為經濟資源有限的人可能難以獲得最先進的植入式醫療設備。

患者對植入式解決方案的偏好

患者越來越傾向於選擇植入式醫療器材而非傳統治療方法，因為他們意識到植入式醫療器材能夠改善生活品質並帶來長期療效。無論是用於治療整形外科疾病的人工關節，或是用於慢性疼痛管理的神經刺激設備，許多植入都能顯著提升患者的功能性和活動能力，因此備受患者青睞。此外，美容植入（例如植入和牙科修補）的日益普及也反映出社會觀念的轉變，即人們越來越傾向於接受有助於提升整體健康和自尊的醫療干預措施。

併發症和失敗的風險

患者和醫護人員通常都對植入手術可能帶來的不利事件保持謹慎，這些不良事件包括設備故障和術後併發症。對醫療植入安全性和有效性的擔憂可能導致患者和醫護人員猶豫不決，阻礙這些技術的廣泛應用。然而，設備故障和併發症不僅會損害患者利益，還會引發法律和監管審查，這可能會進一步抑制市場發展。

新型冠狀病毒（COVID-19）的影響：

全球衛生危機造成的直接衝擊導致預定手術被推遲或取消，進而影響了對各種醫療植入的需求。醫院和醫療機構將資源集中用於應對新冠肺炎病例激增，減少了對非緊急手術的關注。然而，供應鏈中斷、旅行限制和生產放緩也阻礙了醫療植入的生產和分銷。

在預測期內，整形外科植入領域預計將佔據最大的市場佔有率。

骨關節炎、骨折和肌肉骨骼疾病等整形外科疾病發病率的不斷上升，以及全球人口老化，預計將使整形外科植入市場在預測期內佔據最大的市場佔有率。隨著人們追求更高的行動能力和生活品質，包括關節重建和脊椎移植的整形外科植入需求激增。此外，微創手術的日益普及也進一步推動了對整形外科植入的需求，因為這些手術通常恢復時間更短，術後併發症更少。

在預測期內，門診手術中心 (ASC) 細分市場預計將呈現最高的複合年成長率。

由於醫療服務模式的轉變，門診手術中心（ASC）預計將在預測期內實現顯著成長。這種轉變提供了一種比傳統醫院環境更具成本效益、更有效率且以病人為中心的替代方案。與傳統醫院相比，門診手術中心更便捷，等待時間更短，感染風險更低，因此患者越來越傾向於選擇門診手術中心。此外，不斷發展的醫療保健格局強調個人化和專業化護理，這也進一步推動了門診手術中心對醫療植入的需求。

市佔率最大的地區：

憑藉先進的醫療基礎設施和快速老化的人口，北美在整個預測期內佔據了最大的市場佔有率。該國完善的醫療保健體系和有利的報銷環境促進了尖端植入技術的應用。此外，醫療服務提供者、製造商和監管機構之間的策略合作簡化了核准流程，確保了新型和改良型醫療植入能夠及時進入市場。

複合年成長率最高的地區：

預計亞太地區在整個預測期內將保持盈利成長。快速的經濟發展和對技術進步日益成長的關注正在提升該地區的市場地位。尤其值得一提的是，不斷壯大的中產階級和日益增強的健康意識正在推動各個治療領域對醫療植入的需求激增。中國、印度和日本等國的監管機構正積極致力於簡化核准流程，以確保創新且安全的醫療植入能夠有效率地進入市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章：全球醫療植入市場：依產品分類

  • 整形外科植入
    • 髖關節整形外科植入
    • 關節重組
    • 膝關節整形外科植入
    • 脊椎整形外科器械
    • 其他整形外科植入
  • 心血管植入
    • 結構性心臟植入
    • 心律調節器
    • 其他心血管植入
  • 眼科植入
    • 青光眼植入
    • 人工水晶體
    • 其他眼科植入
  • 植入
  • 人工植牙
  • 其他產品

第6章：全球醫療植入市場：依材料分類

  • 陶瓷生物材料
  • 天然生物材料
  • 聚合物生物材料
  • 金屬生物材料
  • 其他材料

第7章 全球醫療植入市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他最終用戶

第8章：全球醫療植入市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • 3M Company
  • Abbott Laboratories
  • Biotronik, Inc
  • Boston Scientific Corporation
  • Institut Straumann AG
  • Johnson & Johnson Medical GmbH
  • Livanova Plc
  • Medtronic plc
  • Novartis International AG
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: SMRC25139

According to Stratistics MRC, the Global Medical Implant Market is accounted for $128.3 billion in 2026 and is expected to reach $260.0 billion by 2034 growing at a CAGR of 9.2% during the forecast period. The medical implant market is designed to be surgically placed within the body to replace or support damaged biological structures, enhance bodily functions, or monitor health conditions. Implantable medical devices serve diverse purposes, such as restoring organ function, managing chronic diseases, and improving mobility. Additionally, cochlear implants help restore hearing, while insulin pumps aid in diabetes management. These devices not only contribute to extending and improving lives but also enable patients to regain functionality.

According to the report published by the American Cancer Society in 2023, 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States compared to 287,850 new breast cancer cases in 2022. According to the Aesthetic Society Statistics, in 2021, there were 147,684 breast implant removal/replacement procedures constituting 6% of surgical revenue.

Market Dynamics:

Driver:

Growing healthcare expenditures

As nations allocate substantial financial resources to enhance healthcare infrastructure and services, there is a parallel increase in the accessibility and adoption of advanced medical technologies, including implantable devices. With a growing emphasis on providing high-quality healthcare, the rise in healthcare expenditures signifies a commitment to advancing medical interventions, and implantable devices, in particular, become integral components in delivering sophisticated, effective, and often life-enhancing solutions for a range of medical conditions.

Restraint:

High cost

The intricate research, development, and manufacturing processes, coupled with the need for stringent regulatory approvals, contribute to elevated production costs. Consequently, these expenses are often transferred to healthcare providers and, ultimately, patients, making implantable solutions financially burdensome. This high economic barrier limits the accessibility of medical implants, particularly in regions with constrained healthcare budgets, and may deter patients from pursuing these advanced treatment options. However, the cost factor exacerbates existing healthcare disparities, as individuals with limited financial means may face challenges in accessing cutting-edge implantable devices.

Opportunity:

Patient preference for implantable solutions

Patients are opting for implantable devices over traditional treatment modalities due to the perceived advantages they offer in terms of improved quality of life and long-term therapeutic benefits. Patients appreciate the potential for enhanced functionality and mobility that many implants provide, whether it is artificial joints for orthopedic conditions or neurostimulators for chronic pain management. Additionally, the growing acceptance of cosmetic implants, such as breast implants or dental prosthetics, reflects a broader societal shift towards embracing medical interventions that contribute to overall well-being and self-esteem.

Threat:

Risk of complications and failures

Patients and healthcare providers alike are often cautious about the potential adverse outcomes associated with implant procedures, ranging from device malfunctions to post-operative complications. Concerns about the safety and efficacy of medical implants can lead to hesitancy among both patients and healthcare professionals, thereby impeding the widespread adoption of these technologies. However, instances of device failures or complications can not only result in harm to patients but may also trigger legal and regulatory scrutiny, further dampening market.

Covid-19 Impact:

The immediate disruption caused by the global health crisis led to elective surgeries being postponed or canceled, affecting the demand for various medical implants. Hospitals and healthcare facilities shifted their focus and resources towards managing the surge in Covid-19 cases, diverting attention from non-urgent procedures. However, supply chain disruptions, restrictions on movement, and manufacturing slowdowns also hampered the production and distribution of medical implants.

The orthopedic implants segment is expected to be the largest during the forecast period

Due to the rising incidence of orthopedic conditions such as osteoarthritis, fractures, and musculoskeletal disorders, coupled with an aging global population, Orthopedic Implants segment is expected to hold the largest share over the projection period. As individuals seek enhanced mobility and improved quality of life, the demand for orthopedic implants, including joint replacements and spinal implants, has surged. Furthermore, the increasing trend towards minimally invasive surgical procedures has further fueled the demand for orthopedic implants, as these procedures often involve shorter recovery times and reduced post-operative complications.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

Due to a shift in healthcare delivery by providing a more cost-effective, efficient, and patient-centric alternative to traditional hospital settings, Ambulatory Surgical Centers segment is poised to witness lucrative growth during the extrapolated period. Patients increasingly prefer ASCs for their convenience, quicker turnaround times, and lower infection risks compared to traditional hospitals. The demand for medical implants in ASCs is further fueled by the evolving landscape of healthcare, emphasizing personalized and specialized care.

Region with largest share:

Owing to a combination of advanced healthcare infrastructure and a rapidly aging population, North America commanded the largest share of the market throughout the extrapolated period. The country's well-established healthcare system, coupled with a favorable reimbursement landscape, encourages the adoption of cutting-edge implant technologies. Moreover, strategic collaborations between healthcare providers, manufacturers, and regulatory bodies facilitate efficient approval processes, ensuring timely market entry for new and improved medical implants.

Region with highest CAGR:

Asia Pacific region is estimated to witness profitable growth throughout the forecast period. Rapid economic development and a growing focus on technological advancements contribute to the region's prominence. In particular, the rising middle-class population, coupled with improved healthcare awareness, has led to an escalating demand for medical implants across various therapeutic areas. Regulatory bodies in countries such as China, India, and Japan are actively working to streamline approval processes, ensuring that innovative and safe medical implants enter the market efficiently.

Key players in the market

Some of the key players in Medical Implant market include 3M Company, Abbott Laboratories, Biotronik, Inc, Boston Scientific Corporation, Institut Straumann AG, Johnson & Johnson Medical GmbH, Livanova Plc, Medtronic plc, Novartis International AG, Smith & Nephew plc and Stryker Corporation.

Key Developments:

In March 2023, Miach Orthopaedics, Inc. entered a distribution agreement with Veteran's Health Medical Supply (VHMS). The agreement provides customers in 236 Department of Defense (DOD) and Department of Veterans Affairs (VA) healthcare facilities access to the Bridge Enhanced ACL Restoration (BEAR) Implant via the ECAT federal contract.

In February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant, designed to simplify surgery and provide strong, stable fixation in small-boned patients.

In April 2022, 3M presently declared that it has gained the technology assets of LeanTec. The acquisition displays 3M's dedication to its "connected bodyshop". The LeanTec technology augments 3M(TM) RepairStack(TM) Performance Solutions.

In February 2022, Abbott declared the world's earliest patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i(TM) pivotal clinical investigation. The implant of Abbott's investigational Aveir(TM) dual-chamber leadless pacemaker depicts a considerable technological milestone for leadless pacing technology.

Products Covered:

  • Orthopedic Implants
  • Cardiovascular Implants
  • Ophthalmic Implants
  • Breast Implants
  • Dental Implants
  • Other Products

Materials Covered:

  • Ceramic Biomaterial
  • Natural Biomaterial
  • Polymers Biomaterial
  • Metallic Biomaterial
  • Other Materials

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Medical Implant Market, By Product

  • 5.1 Introduction
  • 5.2 Orthopedic Implants
    • 5.2.1 Hip Orthopaedic Device
    • 5.2.2 Joint Reconstruction
    • 5.2.3 Knee Orthopedic Devices
    • 5.2.4 Spine Orthopedic Devices
    • 5.2.5 Other Orthopedic Implants
  • 5.3 Cardiovascular Implants
    • 5.3.1 Structural Cardiac Implants
    • 5.3.2 Pacing Devices
    • 5.3.3 Other Cardiovascular Implants
  • 5.4 Ophthalmic Implants
    • 5.4.1 Glaucoma Implants
    • 5.4.2 Intraocular Lens
    • 5.4.3 Other Ophthalmic Implants
  • 5.5 Breast Implants
  • 5.6 Dental Implants
  • 5.7 Other Products

6 Global Medical Implant Market, By Material

  • 6.1 Introduction
  • 6.2 Ceramic Biomaterial
  • 6.3 Natural Biomaterial
  • 6.4 Polymers Biomaterial
  • 6.5 Metallic Biomaterial
  • 6.6 Other Materials

7 Global Medical Implant Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Other End Users

8 Global Medical Implant Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Company
  • 10.2 Abbott Laboratories
  • 10.3 Biotronik, Inc
  • 10.4 Boston Scientific Corporation
  • 10.5 Institut Straumann AG
  • 10.6 Johnson & Johnson Medical GmbH
  • 10.7 Livanova Plc
  • 10.8 Medtronic plc
  • 10.9 Novartis International AG
  • 10.10 Smith & Nephew plc
  • 10.11 Stryker Corporation

List of Tables

  • Table 1 Global Medical Implant Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Medical Implant Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Medical Implant Market Outlook, By Orthopedic Implants (2023-2034) ($MN)
  • Table 4 Global Medical Implant Market Outlook, By Hip Orthopaedic Device (2023-2034) ($MN)
  • Table 5 Global Medical Implant Market Outlook, By Joint Reconstruction (2023-2034) ($MN)
  • Table 6 Global Medical Implant Market Outlook, By Knee Orthopedic Devices (2023-2034) ($MN)
  • Table 7 Global Medical Implant Market Outlook, By Spine Orthopedic Devices (2023-2034) ($MN)
  • Table 8 Global Medical Implant Market Outlook, By Other Orthopedic Implants (2023-2034) ($MN)
  • Table 9 Global Medical Implant Market Outlook, By Cardiovascular Implants (2023-2034) ($MN)
  • Table 10 Global Medical Implant Market Outlook, By Structural Cardiac Implants (2023-2034) ($MN)
  • Table 11 Global Medical Implant Market Outlook, By Pacing Devices (2023-2034) ($MN)
  • Table 12 Global Medical Implant Market Outlook, By Other Cardiovascular Implants (2023-2034) ($MN)
  • Table 13 Global Medical Implant Market Outlook, By Ophthalmic Implants (2023-2034) ($MN)
  • Table 14 Global Medical Implant Market Outlook, By Glaucoma Implants (2023-2034) ($MN)
  • Table 15 Global Medical Implant Market Outlook, By Intraocular Lens (2023-2034) ($MN)
  • Table 16 Global Medical Implant Market Outlook, By Other Ophthalmic Implants (2023-2034) ($MN)
  • Table 17 Global Medical Implant Market Outlook, By Breast Implants (2023-2034) ($MN)
  • Table 18 Global Medical Implant Market Outlook, By Dental Implants (2023-2034) ($MN)
  • Table 19 Global Medical Implant Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 20 Global Medical Implant Market Outlook, By Material (2023-2034) ($MN)
  • Table 21 Global Medical Implant Market Outlook, By Ceramic Biomaterial (2023-2034) ($MN)
  • Table 22 Global Medical Implant Market Outlook, By Natural Biomaterial (2023-2034) ($MN)
  • Table 23 Global Medical Implant Market Outlook, By Polymers Biomaterial (2023-2034) ($MN)
  • Table 24 Global Medical Implant Market Outlook, By Metallic Biomaterial (2023-2034) ($MN)
  • Table 25 Global Medical Implant Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 26 Global Medical Implant Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Medical Implant Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 28 Global Medical Implant Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 29 Global Medical Implant Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.